Unum Group
For the period ended Jun 30, 2025. Filed Jul 30, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Jul 30, 2025
Contents
Corporate Segment
The Corporate segment includes investment income on corporate assets not specifically allocated to a line of business, interest expense on corporate debt, and certain other corporate income and expenses not allocated to a line of business.
| (in millions of dollars) | ||||||
|---|---|---|---|---|---|---|
| Three Months Ended June 30 | Six Months Ended June 30 | |||||
| 2025 | % Change | 2024 | 2025 | % Change | 2024 | |
| Adjusted Operating Revenue | ||||||
| Net Investment Income | $32.3 | 125.9% | $14.3 | $56.2 | 74.0% | $32.3 |
| Other Income (Loss) | (0.3) | (175.0) | 0.4 | (0.3) | (127.3) | 1.1 |
| Total | 32.0 | 117.7 | 14.7 | 55.9 | 67.4 | 33.4 |
| Interest, Debt, and Other Expenses | 63.7 | 6.2 | 60.0 | 128.7 | 3.1 | 124.8 |
| Adjusted Operating Loss | $(31.7) | (30.0) | $(45.3) | $(72.8) | (20.4) | $(91.4) |
Adjusted operating loss decreased in the second quarter and first six months of 2025 relative to the same periods of 2024 due primarily to increased net investment income, which was driven by an increase in miscellaneous investment income and an increase in the level of invested assets.
We expect to continue to generate excess capital on an annual basis through the statutory earnings in our insurance subsidiaries and believe we are well positioned with flexibility to preserve our capital strength while also returning capital to our shareholders. We may experience volatility in net investment income due to changes in the prevailing interest rates, miscellaneous investment income, and the composition and level of invested assets.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.